Content & Editorial Policy – GLP3 Weight Loss

GLP3 Weight Loss is built to be a high-integrity reference for GLP-1–based obesity care and research-only peptide documentation. Our goal is to model how compliant, evidence-aligned communication should look.

Scope

• GLP-1 / incretin science explained in conservative, regulator-aligned terms.
• Neutral documentation for research peptides: identity, context, and cautions.
• No dosing instructions, no lifestyle “hacks,” no miracle claims.

Evidence Standards

• We prioritize peer-reviewed studies, regulatory statements, and consensus guidelines.
• We avoid extrapolating limited data into clinical promises.
• Where evidence is emerging or conflicting, we say so plainly.

AI-Assisted Drafting

We may use AI tools to assist with drafting summaries, but all key pages are curated by humans for accuracy, neutrality, and regulatory alignment.

Research Peptides

• Every peptide page reiterates For Research Use Only.
• We do not encourage unsupervised self-experimentation or off-label injection sourcing.

Conflicts of Interest

If GLP3WeightLoss.com ever forms commercial relationships (e.g., acquisition by a manufacturer), these will be disclosed, and editorial standards will remain transparent.

Corrections & Feedback

To flag an error or request clarification, please use our Contact page. Substantive corrections will be logged and updated.

Nothing on this site is medical advice or an offer to sell prescription products.